OSMOTICA PHARMACEUTICALS PLC's ticker is OSMT and the CUSIP is G6S41R101. A total of 39 filers reported holding OSMOTICA PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 2 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -87.5% | 2 | -71.4% | 0.00% | – |
| Q1 2023 | $8 | 0.0% | 7 | 0.0% | 0.00% | – |
| Q4 2022 | $8 | -99.9% | 7 | 0.0% | 0.00% | – |
| Q3 2022 | $15,000 | +50.0% | 7 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | -94.5% | 7 | -93.5% | 0.00% | – |
| Q1 2022 | $181,000 | +42.5% | 107 | +148.8% | 0.00% | – |
| Q3 2021 | $127,000 | -99.0% | 43 | -99.0% | 0.00% | – |
| Q2 2021 | $13,084,000 | -17.6% | 4,347 | -10.8% | 0.00% | – |
| Q1 2021 | $15,886,000 | +3.1% | 4,873 | +30.3% | 0.00% | – |
| Q4 2020 | $15,413,000 | +18.7% | 3,741 | +55.9% | 0.00% | – |
| Q3 2020 | $12,984,000 | +367.2% | 2,400 | +481.1% | 0.00% | – |
| Q2 2020 | $2,779,000 | -67.2% | 413 | -84.5% | 0.00% | – |
| Q1 2020 | $8,475,000 | +16.7% | 2,665 | +156.5% | 0.00% | – |
| Q4 2019 | $7,263,000 | +4.5% | 1,039 | -42.6% | 0.00% | – |
| Q3 2019 | $6,950,000 | +1.4% | 1,810 | +0.3% | 0.00% | – |
| Q2 2019 | $6,855,000 | – | 1,804 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 14,600,444 | $1,264,399 | 1.11% |
| TITLEIST ASSET MANAGEMENT, LLC | 100,142 | $8,672 | 0.00% |
| Dakota Community Bank & Trust NA | 1,809 | $157 | 0.00% |
| Insight Advisors, LLC/ PA | 75,646 | $6,551 | 0.00% |
| NORTHERN TRUST CORP | 65,334 | $5,658 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 307,266 | $26,609 | 0.00% |
| STATE STREET CORP | 106,487 | $9,222 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 272,584 | $23,606 | 0.00% |
| MORGAN STANLEY | 32,000 | $2,771 | 0.00% |